Understanding methiopropamine, a new psychoactive substance: an in-depth review on its chemistry, pharmacology and implications to human health
International Journal of Legal Medicine · 2024
DOI: 10.1007/s00414-024-03201-7 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Legal Medicine, 2024. Verfasst von Mohd Khairulanwar Bunaim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Universiti Kebangsaan Malaysia, 50300, Kuala Lumpur, Malaysia. Hauptthemen laut MEDLINE: Methamphetamine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 81 Literaturangaben. Gefördert von: Fundamental Research Grant Scheme, Ministry of Higher Education, Malaysia.
Abstract (Originalsprache)
Methiopropamine or 1-(thiophen-2-yl)-2-methylaminopropane (MPA) is a thiophene ring-based structural analogue of methamphetamine, first synthesized in 1942 but become popular when it started to be available for purchase on websites selling 'legal highs' since 2010. While it is legally controlled in many countries, it remains readily accessible and frequently encountered in recreational settings. The growing prevalence of MPA use results in new therapeutic challenges. Relatively few studies have focused on its pharmacodynamics and pharmacokinetics, making it important to better understand its potential risks and harmful effects in humans in terms of its toxicity. This review provides a comprehensive profiling of MPA toxicological properties, including its chemical properties, analytical methods, prevalence, patterns of use, and legal status. Additionally, it discusses the drug's effects on the central nervous system, its potential for addiction, and its adverse physical and mental health effects. Improving the understanding of safety aspects of MPA and how it imposes health threats for public health will guide the development of therapeutic approach of its intoxication and guide the authorities in deciding its legal status.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, Universiti Kebangsaan Malaysia, 50300, Kuala Lumpur, Malaysia.
- Department of Biomedical Sciences and Therapeutics, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah (UMS), 88400, Kota Kinabalu, Sabah, Malaysia.
- Faculty of Medicine, Universiti Kebangsaan Malaysia, 56000, Cheras, Kuala Lumpur, Malaysia.
- Department of Pharmaceutical Life Sciences, Faculty of Pharmacy, Universiti Malaya, 50603, Kuala Lumpur, Malaysia.
- Faculty of Pharmacy, Universiti Kebangsaan Malaysia, 50300, Kuala Lumpur, Malaysia. azrina.azmi@ukm.edu.my.
Förderung
- Fundamental Research Grant Scheme, Ministry of Higher Education, Malaysia
Zitieren
APA
Bunaim, M. K., Damanhuri, H. A., Yow, H. Y., Yaakob, N. S., Makmor-Bakry, M., & Azmi, N. (2024). Understanding methiopropamine, a new psychoactive substance: an in-depth review on its chemistry, pharmacology and implications to human health. International Journal of Legal Medicine. https://doi.org/10.1007/s00414-024-03201-7
Vancouver
Bunaim MK, Damanhuri HA, Yow HY, Yaakob NS, Makmor-Bakry M, Azmi N. Understanding methiopropamine, a new psychoactive substance: an in-depth review on its chemistry, pharmacology and implications to human health. International Journal of Legal Medicine. 2024. doi:10.1007/s00414-024-03201-7
BibTeX
@article{Bunaim2024,
author = {Bunaim, Mohd Khairulanwar and Damanhuri, Hanafi Ahmad and Yow, Hui-Yin and Yaakob, Nor Syafinaz and Makmor-Bakry, Mohd and Azmi, Norazrina},
title = {Understanding methiopropamine, a new psychoactive substance: an in-depth review on its chemistry, pharmacology and implications to human health},
journal = {International Journal of Legal Medicine},
year = {2024},
doi = {10.1007/s00414-024-03201-7}
}
EUVIMED